<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47360/1995-4484-2020-401-406</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-2928</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Особенности поражения аксиального скелета при псориатическом артрите: данные реальной клинической практики</article-title><trans-title-group xml:lang="en"><trans-title>Specific features of axial involvement in psoriatic arthritis: data from real clinical practice</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5015-7143</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Губарь</surname><given-names>Е. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Gubar</surname><given-names>E. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А </p></bio><bio xml:lang="en"><p>Gubar Elena </p><p>34A Kashirskoe Shosse, Moscow 115522 </p></bio><email xlink:type="simple">gubarelena@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6875-4552</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Логинова</surname><given-names>Е. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Loginova</surname><given-names>E. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5968-2403</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Корсакова</surname><given-names>Ю. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Kоrsakova</surname><given-names>Yu. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0579-1131</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коротаева</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Korotayeva</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4285-0869</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глухова</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Glukhova</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3355-2093</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Седунова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sedunova</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>190068, г. Санкт-Петербург, ул. Большая Подьяческая, 30</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2189-3085</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Приставский</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Pristavsky</surname><given-names>I. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>190068, г. Санкт-Петербург, ул. Большая Подьяческая, 30</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2405-2342</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бондарева</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Bondareva</surname><given-names>I. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>650000, г. Кемерово, Октябрьский пр., 22</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2168-8954</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Умнова</surname><given-names>И. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Umnova</surname><given-names>I. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>644111, г. Омск, ул. Березовая, 3</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1598-8360</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Насонов</surname><given-names>Е. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Nasonov</surname><given-names>E. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А</p><p>119991, Москва, ул. Трубецкая, 8, стр. 2</p></bio><bio xml:lang="en"><p>34A Kashirskoe Shosse, Moscow 115522 </p><p>8, Trubetskaya str, bld 2, Moscow 119991 </p></bio><xref ref-type="aff" rid="aff-5"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>VA Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Санкт-Петербургское государственное бюджетное учреждение здравоохранения «Клиническая ревматологическая больница № 25»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinical Rheumatology Hospital №25</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ГАУЗ КО «Кемеровская областная клиническая больница имени С.В. Беляева»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kemerovo Regional Clinical Hospital named after SV Belyaev</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>БУЗОО ОКБ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Omsk Regional Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»; &#13;
ФГБОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>VA Nasonova Research Institute of Rheumatology; I.M. Sechenov First Moscow State Medical University, MOH (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>04</day><month>09</month><year>2020</year></pub-date><volume>58</volume><issue>4</issue><fpage>401</fpage><lpage>406</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Губарь Е.Е., Логинова Е.Ю., Корсакова Ю.Л., Коротаева Т.В., Глухова С.И., Седунова М.В., Приставский И.Н., Бондарева И.Н., Умнова И.Ф., Насонов Е.Л., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Губарь Е.Е., Логинова Е.Ю., Корсакова Ю.Л., Коротаева Т.В., Глухова С.И., Седунова М.В., Приставский И.Н., Бондарева И.Н., Умнова И.Ф., Насонов Е.Л.</copyright-holder><copyright-holder xml:lang="en">Gubar E.E., Loginova E.Y., Kоrsakova Y.L., Korotayeva T.V., Glukhova S.I., Sedunova M.V., Pristavsky I.N., Bondareva I.N., Umnova I.F., Nasonov E.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/2928">https://rsp.mediar-press.net/rsp/article/view/2928</self-uri><abstract><p>Цель исследования – сравнить клинические особенности двух групп больных псориатическим артритом (ПсА): с вовлечением осевого скелета и без аксиального поражения.</p><sec><title>Материал и методы</title><p>Материал и методы. Обследовано 385 больных ПсА (172 мужчины и 213 женщин) из Общероссийского регистра, диагноз соответствовал критериям CASPAR. Помимо стандартного обследования, всем пациентам проводилась, рентгенография таза, определение HLA-B27. Сакроилеит (СИ), по данным рентгенографии (рСИ), регистрировался при наличии двусторонних изменений, соответствующих как минимум II ст., или односторонних – как минимум III ст. по Kellgren. Активность заболевания оценивалась по индексам DAS28 (Disease activity score 28), DAPSA (Disease activity in psoriatic arthritis) и BASDAI (Bath ankylosing spondylitis disease activity index). Оценка интенсивности боли (ОБ) и общая оценка активности заболевания пациентом (ООЗП) проводилась с использованием 100 мм визуальной аналоговой шкалы (ВАШ). Сформированы 2 группы: в первую вошли пациенты с аксиальным поражением, имевшие рСИ – рСИ(+), во вторую – больные без аксиального поражения, у которых рСИ отсутствовал – рСИ(-).</p></sec><sec><title>Результаты</title><p>Результаты. В группу с аксиальным поражением вошли 214 (55,6%) пациентов, 106 мужчин и 108 женщин, в группу без аксиального поражения – 171 (44,4%) пациент, 66 мужчин и 105 женщин (табл. 1). В группе рСИ(+) было достоверно больше лиц мужского пола – 49,5%, чем в группе рСИ(-) – 38,6% (отношение шансов (ОШ) 1,56; 95% доверительный интервал (ДИ) 1,6–2,4; р=0,0324). HLA-В27 выявлялся чаще в группе рСИ(+), чем в группе рСИ(-), соответственно у 62 из 126 и у 26 из 78 больных (OШ 1,9; 95% ДИ 1,1–3,5). При наличии рСИ отмечался более тяжелый эрозивный периферический артрит, чем при его отсутствии. Медиана числа болезненных суставов (ЧБС) составила 9 [14; 18] и 6 [3; 12] (р=0,02), а эрозии на рентгенограммах стоп обнаружены у 58 (27,1%) и 29 (17%) пациентов соответственно (OШ 1,8; 95% ДИ 1,1–3,0). При наличии рСИ активность заболевания была выше, чем при его отсутствии. Медиана индекса DAS28 составляла 4,3 [3,3; 5,6] и 4,05 [3,03; 4,88] (р=0,02), DAPSA – 28,40 [15,65; 43,65] и 20,0 [12,45; 30,0] (р &lt;0,01), BASDAI – 1,6 [0; 5,1] и 0 [0; 4,5] (р &lt;0,01), C-реактивного белка (СРБ) – 0,9 [0,4; 2,2] мг/дл и 0,8 [0,3; 1,3] мг/дл соответственно (р=0,029). ООЗП по ВАШ – 56,5 [42,3; 70,0] мм и 50,0 [30,0; 60,0] мм (р &lt;0,01); ООЗВ – 54,0 [40,0; 69,5] мм и 40,0 [25,5; 50,0] мм (р &lt;0,01); ОБ по ВАШ – 50,0 [40,0; 70,0] мм и 50,0 [20,5; 58,8] мм соответственно (р &lt;0,01). В группе рСИ(+) чаще наблюдалось поражение энтезисов, которое оценивалось по индексу LEI и чаще встречались дактилиты. Медиана индекса LEI составила 0 [0; 2] и 0 [0; 1] (p=0,02), а дактилиты выявлены у 71 (31,2%) и 32 (18,7%) пациентов соответственно (OШ 2,2; 95% ДИ 1,3–3,5). У пациентов с рСИ(+) отмечалось более тяжелое поражение кожи, чем при рСИ(-). Индекс BSA (Body Surface Area) &gt;3% был у 94 (43,9%) и 57 (33,3%) больных соответственно (OШ 1,7; 95% ДИ 1,03–2,4). При наличии аксиального поражения отмечались более выраженные функциональные нарушения, чем при его отсутствии. Медиана HAQ составляла соответственно 1,0 [0,6; 1,5] и 0 [0-2,2] (р=0,02).</p></sec><sec><title>Выводы</title><p> Выводы. При вовлечении осевого скелета у больных ПсА наблюдается более тяжелое поражение суставов, большая частота энтезитов и дактилитов, более выраженный псориаз, что следует учитывать при выборе тактики лечения. </p></sec></abstract><trans-abstract xml:lang="en"><p>Objective. To compare clinical features in psoriatic arthritis (PsA) patients with and without axial involvement. Subjects and methods. 385 PsA patients (172 males and 213 females) from National PsA Register were examined, their diagnosis verified according to CASPAR criteria. Patients’ median age was 45 [35; 54] years, median disease duration – 5,1 [0; 8] years. Pelvis X-ray and HLA-B27 levels in addition to physical examinations were obtained in all patients. Sacroiliitis (SI) was established based on radiographic findings (rSI) including bilateral changes corresponding to at least stage II, or unilateral – corresponding to at least stage III of Kellgren-Lawrence radiographic grading scale. Patients’ radiographs were evaluated by an independent radiologist. Disease activity was assessed using the DAS28 (Disease activity score 28), DAS (Disease activity in psoriatic arthritis) and BASDAI (Bath ankylosing spondylitis disease activity index) scales. 100 mm visual analog scale (VAS) was used for assessment of pain intensity (PI) and the Patient’s Global Assessment of Disease Activity (PtGA). Patients were distributed into two groups: Group 1 included rSI(+) patients, Group 2 – patients without radiologically confirmed SI – rSI (-). Results. Group 1 included 214 (55,6%) patients with axial involvement, 106 males and 108 females, Group 2 rSI (-) – 171 (44,4%) patients, 66 males and 105 females Proportion of men was significantly higher in RSi(+) group – 49,5% vs 38,6% in rSi(-) group (Odds Ratio, OR – 1,56, 95% CI 1,6-2,4; р = 0,0324). Patient’s median age was 45 [35; 54] and 46 [34; 56] years, respectively (p=0,911). Higher rates of HLA-В27 positivity were found in group rSI(+) patients, than in rSI(-), respectively in 62 out of 126 and in 26 out of 78 patients (OR 1,9, 95% CI 1,1-3,5). Patients from RSI(+) group had more severe erosive peripheral arthritis. Median tender joint counts (TJC) were 9 [14; 18] and 6 [3; 12] (р=0,02), while radiographic feet bone erosions were found in 58 (27,1%) and 29 (17%) patients, respectively (OR 1,8, 95% CI 1,1-3,0). Disease activity was higher in rSI(+) group. Median DAS28 score was 4,3 [3,3; 5,6] and 4,05 [3,03; 4,88] (р=0,02), DAPSA – 28,40 [15,65; 43,65] and 20,0 [12,45; 30,0], (р &lt; 0,01), BASDAI – 1,6 [0; 5,1] and 0 [0; 4,5] (р &lt; 0,01), C-reactive protein (CRP) – 0,9 [0,4; 2,2] mg/dl and 0,8 [0,3; 1,3] mg/dl, respectively (р=0,029). PtGA VAS values were 56,5 [42,3; 70,0] mm and 50,0 [30,0; 60,0] mm (р &lt; 0,01); physicians global assessment (PGA) – 54,0 [40,0; 69,5] mm and 40,0 [25,5; 50,0] mm (р &lt; 0,01); PI VAS values were 50,0 [40,0; 70,0] mm and 50,0 [20,5; 58,8] mm, respectively (р &lt; 0,01). Higher rates of entheses involvement based on the Leeds Enthesitis Index (LEI) and dactylitis were documented in rSI(+) group. Median LEI score was 0 [0; 2] and 0 [0; 1] (p=0,02), while dactylitis was established in 71 (31,2%) and 32 (18,7%) patients, respectively (OR 2,2, 95% CI 1,3-3,5). More severe cutaneous involvement was also found in rSI(+) patients as compared to rSI (-). BSA (Body Surface Area) &gt; 3% involvement was established in 94 (43,9%) and 57 (33,3%) patients, respectively (OR 1,7, 95% CI 1,03-2,4). Axial involvement was associated with more pronounced functional impairment. Median HAQ was 1,0 [0,6; 1,5] and 0 [0-2,2] (р=0,02). Conclusion. Axial involvement in PsA patients is associated with more severe articular damage, higher enthesitis and dactylitis rates, more severe psoriasis, which should be considered when planning treatment.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>аксиальный псориатический артрит</kwd><kwd>сакроилеит при рентгенографии</kwd><kwd>антиген HLA B27</kwd></kwd-group><kwd-group xml:lang="en"><kwd>axial psoriatic arthritis</kwd><kwd>radiological sacroiliitis</kwd><kwd>HLA B27</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Baraliakos X, Coates LC, Braun J. The involvement of the spine in psoriatic arthritis. Clin Exp Rheumatol. 2015;33( Suppl 93):S31-5</mixed-citation><mixed-citation xml:lang="en">Baraliakos X, Coates LC, Braun J. The involvement of the spine in psoriatic arthritis. Clin Exp Rheumatol. 2015;33( Suppl 93):S31-5</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Mease PJ, Palmer JB, Liu M, et al. Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. J Rheumatol. 2018;45(10):1389-1396. doi:10.3899/jrheum.171094</mixed-citation><mixed-citation xml:lang="en">Mease PJ, Palmer JB, Liu M, et al. Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. J Rheumatol. 2018;45(10):1389-1396. doi:10.3899/jrheum.171094</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Aydin SZ, Kucuksahin O, Kilic L, et al. Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real life. Clin Rheumatol. 2018;37(12):3443-3448. doi: 10.1007/s10067-018-4173-4</mixed-citation><mixed-citation xml:lang="en">Aydin SZ, Kucuksahin O, Kilic L, et al. Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real life. Clin Rheumatol. 2018;37(12):3443-3448. doi: 10.1007/s10067-018-4173-4</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Fernandez-Sueiro JL. The Challenge and Need of Defining Axial Psoriatic Arthritis. J Rheumatol. 2009 Dec;36(12):2633-4. doi: 10.3899/jrheum.091023</mixed-citation><mixed-citation xml:lang="en">Fernandez-Sueiro JL. The Challenge and Need of Defining Axial Psoriatic Arthritis. J Rheumatol. 2009 Dec;36(12):2633-4. doi: 10.3899/jrheum.091023</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Jadon DR, Sengupta R, Nightingale A, et al. Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis. Ann Rheum Dis. 2017;76(4):701-707. doi: 10.1136/annrheumdis-2016-209853</mixed-citation><mixed-citation xml:lang="en">Jadon DR, Sengupta R, Nightingale A, et al. Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis. Ann Rheum Dis. 2017;76(4):701-707. doi: 10.1136/annrheumdis-2016-209853</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Губарь ЕЕ, Логинова ЕЮ, Смирнов АВ и др. Клиникоинструментальная характеристика аксиального поражения при раннем периферическом псориатическом артрите. (Данные исследования РЕМАРКА). Научно-практическая ревматология 2018;56(1):34-40 [Gubar EE, Loginova EYu, Smirnov AV, et al. Clinical and instrumental characteristics of axial lesion in early peripheral psoriatic arthritis (DATA of REMARCA study). Nauchno-Prakticheskaya Revmatologiya= Rheumatology Science and Practice. 2018;56(1):34-40. (In Russ.)]. doi:10.14412/1995-4484-2018-34-40</mixed-citation><mixed-citation xml:lang="en">Губарь ЕЕ, Логинова ЕЮ, Смирнов АВ и др. Клиникоинструментальная характеристика аксиального поражения при раннем периферическом псориатическом артрите. (Данные исследования РЕМАРКА). Научно-практическая ревматология 2018;56(1):34-40 [Gubar EE, Loginova EYu, Smirnov AV, et al. Clinical and instrumental characteristics of axial lesion in early peripheral psoriatic arthritis (DATA of REMARCA study). Nauchno-Prakticheskaya Revmatologiya= Rheumatology Science and Practice. 2018;56(1):34-40. (In Russ.)]. doi:10.14412/1995-4484-2018-34-40</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Haroon M, Winchester R, Giles JT et al. Clinical and genetic associations of radiographic sacroiliitis and its different patterns in psoriatic arthritis. Clin Exp Rheumatol. 2017; 35 (2): 270-276</mixed-citation><mixed-citation xml:lang="en">Haroon M, Winchester R, Giles JT et al. Clinical and genetic associations of radiographic sacroiliitis and its different patterns in psoriatic arthritis. Clin Exp Rheumatol. 2017; 35 (2): 270-276</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Van den Bosch F, Coates L. Clinical management of psoriatic arthritis. Lancet. 2018;391(10136):2285-2294. doi:10.1016/S0140-6736(18)30949-8</mixed-citation><mixed-citation xml:lang="en">Van den Bosch F, Coates L. Clinical management of psoriatic arthritis. Lancet. 2018;391(10136):2285-2294. doi:10.1016/S0140-6736(18)30949-8</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Van der Heijde D, Ramiro S, Landewé R et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770</mixed-citation><mixed-citation xml:lang="en">Van der Heijde D, Ramiro S, Landewé R et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor W, Gladman D, Helliwell P et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665-73. doi::10.1002/art.21972</mixed-citation><mixed-citation xml:lang="en">Taylor W, Gladman D, Helliwell P et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665-73. doi::10.1002/art.21972</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Healy PJ, Helliwell PS. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Care and Research. 2008;59(5):686–691. doi: 10.1002/art.23568</mixed-citation><mixed-citation xml:lang="en">Healy PJ, Helliwell PS. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Care and Research. 2008;59(5):686–691. doi: 10.1002/art.23568</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica.1978;157(4):238-44</mixed-citation><mixed-citation xml:lang="en">Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica.1978;157(4):238-44</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Амирджанова ВН, Койлубаева ГМ, Горячев ДВ и др. Валидация русско-язычной версии HAQ. Научнопрактическая ревматология. 2004;2:59-65. [Amirdzhanova VN, Koilubaeva GM, Gorjachev DV et al. Validation of the Russian language version of HAQ. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2004;2:59-65. (in Russ)]</mixed-citation><mixed-citation xml:lang="en">Амирджанова ВН, Койлубаева ГМ, Горячев ДВ и др. Валидация русско-язычной версии HAQ. Научнопрактическая ревматология. 2004;2:59-65. [Amirdzhanova VN, Koilubaeva GM, Gorjachev DV et al. Validation of the Russian language version of HAQ. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2004;2:59-65. (in Russ)]</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Sze JT, Packham JC, Milica K et al. The prevalence of axial involvement in psoriasis or psoriatic arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2019; 58(3) kez107.068, https://doi.org/10.1093/rheumatology/kez107.068</mixed-citation><mixed-citation xml:lang="en">Sze JT, Packham JC, Milica K et al. The prevalence of axial involvement in psoriasis or psoriatic arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2019; 58(3) kez107.068, https://doi.org/10.1093/rheumatology/kez107.068</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Aydin SZ, Kilic L, Kucuksahin O et al. 2017 Performances of inflammatory back pain criteria in axial psoriatic arthritis. Rheumatology (Oxford). 2017;56(11):2031-2032. doi: 10.1093/rheumatology/kex307</mixed-citation><mixed-citation xml:lang="en">Aydin SZ, Kilic L, Kucuksahin O et al. 2017 Performances of inflammatory back pain criteria in axial psoriatic arthritis. Rheumatology (Oxford). 2017;56(11):2031-2032. doi: 10.1093/rheumatology/kex307</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Haroon M, Gallagher P, FitzGerald O. Inflammatory back pain criteria perform well in subset of patients with active axial psoriatic arthritis but not among patients with established axial disease. Ann Rheum Dis. 2019;78(7):1003-1004. doi: 10.1136/annrheumdis-2018-214583</mixed-citation><mixed-citation xml:lang="en">Haroon M, Gallagher P, FitzGerald O. Inflammatory back pain criteria perform well in subset of patients with active axial psoriatic arthritis but not among patients with established axial disease. Ann Rheum Dis. 2019;78(7):1003-1004. doi: 10.1136/annrheumdis-2018-214583</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов ЕЛ, Коротаева ТВ, Лила АМ, Кубанов АА. Можно ли предотвратить развитие псориатического артрита у пациентов с псориазом? Научно-практическая ревматология. 2019;57(3):250–254 [Nasonov EL, Korotaeva TV, Lila AM, Kubanov A. Can the development of psoriatic arthritis be prevented in patients with psoriasis? Nauchno-Prakticheskaya Revmatologiya= Rheumatology Science and Practice. 2019;57(3):250-254. (In Russ.)]. Doi:10.14412/1995-4484-2019-250-254</mixed-citation><mixed-citation xml:lang="en">Насонов ЕЛ, Коротаева ТВ, Лила АМ, Кубанов АА. Можно ли предотвратить развитие псориатического артрита у пациентов с псориазом? Научно-практическая ревматология. 2019;57(3):250–254 [Nasonov EL, Korotaeva TV, Lila AM, Kubanov A. Can the development of psoriatic arthritis be prevented in patients with psoriasis? Nauchno-Prakticheskaya Revmatologiya= Rheumatology Science and Practice. 2019;57(3):250-254. (In Russ.)]. Doi:10.14412/1995-4484-2019-250-254</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Feld J, Ye JY, Chandran V, et al. Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis? Rheumatology (Oxford). 2019 doi:10.1093/rheumatology/kez457</mixed-citation><mixed-citation xml:lang="en">Feld J, Ye JY, Chandran V, et al. Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis? Rheumatology (Oxford). 2019 doi:10.1093/rheumatology/kez457</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Glintborg B, Sørensen IJ, Østergaard M. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry. J Rheumatol. 2017;44(1):59-69. doi: 10.3899/jrheum.160958</mixed-citation><mixed-citation xml:lang="en">Glintborg B, Sørensen IJ, Østergaard M. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry. J Rheumatol. 2017;44(1):59-69. doi: 10.3899/jrheum.160958</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Singh JA, Guyatt G, Ogdie A, et al. 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Care Res (Hoboken). 2019;71(1):2-29. doi: 10.1002/acr.23789</mixed-citation><mixed-citation xml:lang="en">Singh JA, Guyatt G, Ogdie A, et al. 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Care Res (Hoboken). 2019;71(1):2-29. doi: 10.1002/acr.23789</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
